{"id":"https://openalex.org/W1964657944","doi":"https://doi.org/10.1089/dia.2010.0028","title":"Sustained Efficacy of Continuous Subcutaneous Insulin Infusion in Type 1 Diabetes Subjects with Recurrent Non-Severe and Severe Hypoglycemia and Hypoglycemia Unawareness: A Pilot Study","display_name":"Sustained Efficacy of Continuous Subcutaneous Insulin Infusion in Type 1 Diabetes Subjects with Recurrent Non-Severe and Severe Hypoglycemia and Hypoglycemia Unawareness: A Pilot Study","alternate_titles":[],"publication_year":2010,"publication_date":"2010-07-01","ids":{"openalex":"https://openalex.org/W1964657944","doi":"https://doi.org/10.1089/dia.2010.0028","mag":"1964657944","pmid":"https://pubmed.ncbi.nlm.nih.gov/20597825"},"language":"en","primary_location":{"id":"doi:10.1089/dia.2010.0028","doi":"https://doi.org/10.1089/dia.2010.0028","is_oa":false,"landing_page_url":"https://doi.org/10.1089/dia.2010.0028","pdf_url":null,"source":{"id":"https://openalex.org/S67495602","display_name":"Diabetes Technology & Therapeutics","issn_l":"1520-9156","issn":["1520-9156","1557-8593"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Technology &amp; Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1964657944"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069341912","display_name":"Marga Gim\u00e9nez","orcid":"https://orcid.org/0000-0003-2976-1690","observed_orcids":["https://orcid.org/0000-0003-2976-1690"]},"institutions":[{"id":"https://openalex.org/I4210115097","display_name":"Hospital Cl\u00ednic de Barcelona","ror":"https://ror.org/02a2kzf50","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210115097"]},{"id":"https://openalex.org/I4210160192","display_name":"Consorci Institut D'Investigacions Biomediques August Pi I Sunyer","ror":"https://ror.org/054vayn55","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210115097","https://openalex.org/I4210160192","https://openalex.org/I4387153040","https://openalex.org/I4403928279"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Marga Gim\u00e9nez","raw_affiliation_strings":["Endocrinology and Diabetes Unit, Institute of Biomedical Investigations August Pi i Sunyer; CIBER of Diabetes and Associated Metabolic Diseases; and Hospital Cl\u00ednic i Universitari, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Endocrinology and Diabetes Unit, Institute of Biomedical Investigations August Pi i Sunyer; CIBER of Diabetes and Associated Metabolic Diseases; and Hospital Cl\u00ednic i Universitari, Barcelona, Spain","institution_ids":["https://openalex.org/I4210115097","https://openalex.org/I4210160192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027588546","display_name":"Merc\u00e8 Lara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115097","display_name":"Hospital Cl\u00ednic de Barcelona","ror":"https://ror.org/02a2kzf50","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210115097"]},{"id":"https://openalex.org/I4210160192","display_name":"Consorci Institut D'Investigacions Biomediques August Pi I Sunyer","ror":"https://ror.org/054vayn55","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210115097","https://openalex.org/I4210160192","https://openalex.org/I4387153040","https://openalex.org/I4403928279"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Merc\u00e8 Lara","raw_affiliation_strings":["Endocrinology and Diabetes Unit, Institute of Biomedical Investigations August Pi i Sunyer; CIBER of Diabetes and Associated Metabolic Diseases; and Hospital Cl\u00ednic i Universitari, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Endocrinology and Diabetes Unit, Institute of Biomedical Investigations August Pi i Sunyer; CIBER of Diabetes and Associated Metabolic Diseases; and Hospital Cl\u00ednic i Universitari, Barcelona, Spain","institution_ids":["https://openalex.org/I4210115097","https://openalex.org/I4210160192"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5084120269","display_name":"Ignacio Conget","orcid":"https://orcid.org/0000-0002-5532-5449","observed_orcids":["https://orcid.org/0000-0002-5532-5449"]},"institutions":[{"id":"https://openalex.org/I4210115097","display_name":"Hospital Cl\u00ednic de Barcelona","ror":"https://ror.org/02a2kzf50","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210115097"]},{"id":"https://openalex.org/I4210160192","display_name":"Consorci Institut D'Investigacions Biomediques August Pi I Sunyer","ror":"https://ror.org/054vayn55","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210115097","https://openalex.org/I4210160192","https://openalex.org/I4387153040","https://openalex.org/I4403928279"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Ignacio Conget","raw_affiliation_strings":["Endocrinology and Diabetes Unit, Institute of Biomedical Investigations August Pi i Sunyer; CIBER of Diabetes and Associated Metabolic Diseases; and Hospital Cl\u00ednic i Universitari, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Endocrinology and Diabetes Unit, Institute of Biomedical Investigations August Pi i Sunyer; CIBER of Diabetes and Associated Metabolic Diseases; and Hospital Cl\u00ednic i Universitari, Barcelona, Spain","institution_ids":["https://openalex.org/I4210115097","https://openalex.org/I4210160192"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.3174,"has_fulltext":false,"cited_by_count":39,"citation_normalized_percentile":{"value":0.87634919,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"12","issue":"7","first_page":"517","last_page":"521"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11171","display_name":"Diabetes and associated disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10793","display_name":"Diabetes Management and Education","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-1-diabetes","display_name":"type 1 diabetes","score":0.8679999709129333},{"id":"https://openalex.org/keywords/continuous-subcutaneous-insulin-infusion","display_name":"insulin pump therapy","score":0.9950000047683716},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.9120000004768372},{"id":"https://openalex.org/keywords/hypoglycemia-unawareness","display_name":"hypoglycemia unawareness","score":0.9440000057220459},{"id":"https://openalex.org/keywords/severe-hypoglycemia","display_name":"severe hypoglycemia","score":0.8479999899864197},{"id":"https://openalex.org/keywords/continuous-glucose-monitoring","display_name":"continuous glucose monitoring","score":0.8420000076293945},{"id":"https://openalex.org/keywords/glycemic-variability","display_name":"glycemic variability","score":0.7300000190734863},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.828000009059906},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.6179999709129333},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.7730000019073486},{"id":"https://openalex.org/keywords/hypoglycemia-incidence","display_name":"hypoglycemia incidence","score":0.5289999842643738}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9531481266021729},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.9347203969955444},{"id":"https://openalex.org/C2781232474","wikidata":"https://www.wikidata.org/wiki/Q124407","display_name":"Type 1 diabetes","level":3,"score":0.6929082870483398},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.6469683051109314},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.6291056871414185},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5407874584197998},{"id":"https://openalex.org/C2986379492","wikidata":"https://www.wikidata.org/wiki/Q1638492","display_name":"Continuous glucose monitoring","level":4,"score":0.5120337605476379},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.42656630277633667},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.37808701395988464},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.35108309984207153}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003922","descriptor_name":"Diabetes Mellitus, Type 1","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003922","descriptor_name":"Diabetes Mellitus, Type 1","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003922","descriptor_name":"Diabetes Mellitus, Type 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007003","descriptor_name":"Hypoglycemia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D007003","descriptor_name":"Hypoglycemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007003","descriptor_name":"Hypoglycemia","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007003","descriptor_name":"Hypoglycemia","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007332","descriptor_name":"Insulin Infusion Systems","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010865","descriptor_name":"Pilot Projects","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015918","descriptor_name":"Infusion Pumps, Implantable","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1089/dia.2010.0028","doi":"https://doi.org/10.1089/dia.2010.0028","is_oa":false,"landing_page_url":"https://doi.org/10.1089/dia.2010.0028","pdf_url":null,"source":{"id":"https://openalex.org/S67495602","display_name":"Diabetes Technology & Therapeutics","issn_l":"1520-9156","issn":["1520-9156","1557-8593"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Technology &amp; Therapeutics","raw_type":"journal-article"},{"id":"pmid:20597825","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20597825","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes technology & therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W113695596","https://openalex.org/W1531505795","https://openalex.org/W1978166811","https://openalex.org/W1992483091","https://openalex.org/W2012986429","https://openalex.org/W2015818981","https://openalex.org/W2029640106","https://openalex.org/W2031185062","https://openalex.org/W2032951567","https://openalex.org/W2037385875","https://openalex.org/W2069248010","https://openalex.org/W2075943241","https://openalex.org/W2082439598","https://openalex.org/W2084202677","https://openalex.org/W2085621596","https://openalex.org/W2090413848","https://openalex.org/W2111363594","https://openalex.org/W2124282046","https://openalex.org/W2141452347","https://openalex.org/W2144819343","https://openalex.org/W2144991899","https://openalex.org/W2145562665","https://openalex.org/W2149637692","https://openalex.org/W2151487860","https://openalex.org/W2167321173","https://openalex.org/W2190748907","https://openalex.org/W2329298049","https://openalex.org/W2396271197","https://openalex.org/W2418127978","https://openalex.org/W4252759459","https://openalex.org/W4254695749","https://openalex.org/W4298228289"],"related_works":["https://openalex.org/W2952190280","https://openalex.org/W2141452347","https://openalex.org/W2020552067","https://openalex.org/W2098815585","https://openalex.org/W1490382590","https://openalex.org/W2924672833","https://openalex.org/W1896904616","https://openalex.org/W3208089884","https://openalex.org/W3004088820","https://openalex.org/W2800556369"],"abstract_inverted_index":{"BACKGROUND:":[0],"This":[1],"study":[2],"evaluated":[3],"the":[4,69,80,131,172,194,197,227,246,293],"effect":[5],"of":[6,44,51,118,155,162,176,196,229,248,268,275,295,313,328],"CSII":[7,276,315,338],"on":[8,12,48],"hypoglycemia":[9,26,87,166,308,343],"awareness":[10,88],"and":[11,53,60,73,86,127,245,335,345],"glucose":[13,94],"profile":[14,348],"in":[15,115,291,302,324,349,363],"type":[16],"1":[17],"diabetes":[18,364],"(T1D)":[19],"subjects":[20,34,132,137,164,329,351],"with":[21,41,330,352,360],"repeated":[22,333,353],"non-severe":[23],"or":[24,28,57],"severe":[25],"(NS":[27],"SH,":[29],"respectively).":[30],"METHODS:":[31],"We":[32],"included":[33,139],"(1)":[35],"older":[36],"than":[37,62,75],"18":[38],"years,":[39,46],"(2)":[40],"T1D":[42,331,350],"duration":[43],">5":[45],"(3)":[47],"multiple":[49],"doses":[50],"insulin,":[52],"(4)":[54],"without":[55,332],"micro-":[56],"macrovascular":[58],"complications":[59],"more":[61,74],"four":[63],"NS":[64],"events":[65,78],"per":[66,180,209],"week":[67,181],"(in":[68,79],"last":[70,81],"8":[71],"weeks)":[72],"two":[76],"SH":[77,202],"2":[82],"years).":[83],"NS/SH":[84],"episodes":[85,179,203],"were":[89,133,138],"evaluated.":[90,123],"A":[91,105],"72-h":[92],"continuous":[93,100],"monitoring":[95],"(CGM)":[96],"was":[97,108,121,297],"performed":[98],"before":[99],"subcutaneous":[101],"insulin":[102],"infusion":[103],"(CSII).":[104],"hypoglycemia-induced":[106],"test":[107],"used":[109],"to":[110,189,211,238,256,281,305,317],"evaluate":[111],"each":[112],"patient's":[113],"symptoms":[114],"euglycemia/hypoglycemia.":[116],"Quality":[117],"life":[119],"(QoL)":[120],"also":[122,358],"After":[124],"6,":[125],"12,":[126],"24":[128,216,264,273,311],"months,":[129],"all":[130,292],"reevaluated.":[134],"RESULTS:":[135],"Twenty":[136],"(34.0":[140],"+/-":[141,149,152,185,191,207,213,236,240,254,258,278,283],"7.5":[142],"years":[143,154],"old,":[144],"12":[145],"women,":[146],"A1c":[147,222],"6.7":[148],"1.1%,":[150],"16.2":[151],"6.6":[153],"diabetes'":[156],"duration).":[157],"At":[158],"baseline,":[159],"19":[160,284],"out":[161,175],"20":[163],"displayed":[165],"unawareness,":[167],"which":[168],"diminished":[169,182,271],"significantly":[170],"during":[171],"follow-up":[173,198],"(3":[174],"20).":[177],"NH":[178,334],"from":[183,205,321],"5.40":[184],"2.09":[186],"at":[187,193],"baseline":[188],"2.75":[190],"1.74":[192],"end":[195],"(P":[199,218],"<":[200,219,287],"0.001).":[201,220],"fell":[204],"1.25":[206],"0.44":[208],"subject-year":[210],"0.05":[212],"0.22":[214],"after":[215,263,272,310],"months":[217,274,312],"Hemoglobin":[221],"remained":[223],"unaltered.":[224],"With":[225],"CGM,":[226],"percentage":[228,247],"values":[230,249],"within":[231],"70-180":[232],"mg/dL":[233,251,280],"increased":[234],"(53.2":[235],"11.0%":[237],"60.3":[239],"17.1%,":[241],"P":[242,260,286],"=":[243,261],"0.13),":[244],"<70":[250],"decreased":[252],"(13.7":[253],"9.4%":[255],"9.1":[257],"5.2%,":[259],"0.07),":[262],"months.":[265],"Mean":[266],"amplitude":[267],"glycemic":[269,347],"excursions":[270],"(136":[277],"28":[279],"115":[282],"mg/dL;":[285],"0.02).":[288],"An":[289],"improvement":[290,362],"aspects":[294],"QoL":[296],"observed.":[298],"The":[299],"basal":[300],"alteration":[301],"symptom":[303],"response":[304,319],"an":[306,361],"induced":[307],"improved":[309],"initiating":[314],"leading":[316],"a":[318,325],"indistiguishable":[320],"that":[322],"observed":[323],"control":[326],"group":[327],"SH.":[336],"CONCLUSIONS:":[337],"prevents":[339],"hypoglycemic":[340],"episodes,":[341],"improves":[342],"awareness,":[344],"ameliorates":[346],"NS/SH.":[354],"Its":[355],"use":[356],"is":[357],"associated":[359],"QoL.":[365]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1964657944","counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
